secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK:        0000875320
Form:       8-K
Filed at:   2024-08-16T23:59:59+00:00
Accession:  0000875320-24-000207
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Vertex extends Boston headquarters leases to 2044, adding renewal options
-------------------------------------------------------------------------

- Extended combined ~1.1 million sq ft of office and lab space under two leases in Boston.
- Lease term extended from December 2028 to June 30, 2044, with options for two additional ten-year periods.
- Amendments signed with SNH Seaport LLC on August 15, 2024.
- Previous lease had a single 10-year extension option; new terms provide up to 20 additional years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875320/000087532024000207/0000875320-24-000207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875320/000087532024000207/vrtx-20240815.htm
  HTML page:      https://secwatch.observer/filing/0000875320-24-000207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer